154
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Causal Effects of Lipids-Related Metabolites on Androgenic Alopecia: A Mendelian Randomization Study

, ORCID Icon, , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 409-416 | Received 07 Nov 2023, Accepted 30 Jan 2024, Published online: 12 Feb 2024

References

  • Gonzalez-Cantero A, Arias-Santiago S, Buendía-Eisman A, et al. Do dermatologic diagnosis change in hot vs. Cold periods of the year? A sub-analysis of the DIADERM national sample (Spain 2016). Actas Dermosifiliogr. 2019;110(9):734–743. doi:10.1016/j.ad.2019.02.004
  • Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759–3781. doi:10.1111/jocd.14537
  • Deng Y, Wang M, He Y, Liu F, Chen L, Cellular Senescence: XX. Ageing and androgenetic alopecia. Dermatology. 2023;239(4):533–541. doi:10.1159/000530681
  • Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidaemia in men and woman with androgenic alopecia. Acta Derm Venereol. 2010;90(5):485–487. doi:10.2340/00015555-0926
  • Vora RV, Kota R, Singhal RR, Anjaneyan G. Clinical profile of androgenic alopecia and its association with cardiovascular risk factors. Indian J Dermatol. 2019;64(1):19–22. doi:10.4103/ijd.IJD_526_16
  • Ertas R, Orscelik O, Kartal D, et al. Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk. Blood Press. 2016;25(3):141–148. doi:10.3109/08037051.2015.1111021
  • Grandys M, Majerczak J, Zapart-Bukowska J, Duda K, Kulpa JK, Zoladz JA. Lowered Serum testosterone concentration is associated with enhanced inflammation and worsened lipid profile in men. Front Endocrinol. 2021;12:735638. doi:10.3389/fendo.2021.735638
  • Jing J, Ding N, Wang D, et al. Oxidized-LDL inhibits testosterone biosynthesis by affecting mitochondrial function and the p38 MAPK/COX-2 signaling pathway in leydig cells. Cell Death Dis. 2020;11(8):626. doi:10.1038/s41419-020-02751-z
  • Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98. doi:10.1093/hmg/ddu328
  • Kettunen J, Demirkan A, Würtz P, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016;7(1):11122. doi:10.1038/ncomms11122
  • Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961–1974. doi:10.1093/ije/dyw220
  • Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–389. doi:10.1007/s10654-017-0255-x
  • Ho CY, Chen JY, Hsu WL, et al. Female pattern hair loss: an overview with focus on the genetics. Genes. 2023;14(7):7. doi:10.3390/genes14071326
  • Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701–715. doi:10.1007/s40265-023-01880-x
  • Redmond LC, Limbu S, Farjo B, Messenger AG, Higgins CA. Male pattern hair loss: can developmental origins explain the pattern? Exp Dermatol. 2023;32(7):1174–1181. doi:10.1111/exd.14839
  • Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020;21(1):69–84. doi:10.1007/s40257-019-00479-x
  • Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019;80(6):1497–1506. doi:10.1016/j.jaad.2018.08.062
  • Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol. 1998;110(6):849–853. doi:10.1046/j.1523-1747.1998.00224.x
  • Senmaru T, Fukui M, Okada H, et al. Testosterone deficiency induces markedly decreased serum triglycerides, increased small dense LDL, and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet. Metabolism. 2013;62(6):851–860. doi:10.1016/j.metabol.2012.12.007
  • Kim MW, Shin IS, Yoon HS, Cho S, Park HS. Lipid profile in patients with androgenetic alopecia: a meta-analysis. J Eur Acad Dermatol Venereol. 2017;31(6):942–951. doi:10.1111/jdv.14000
  • Bakry OA, El Farargy SM, Ghanayem N, Soliman A. Atherogenic index of plasma in non-obese women with androgenetic alopecia. Int J Dermatol. 2015;54(9):e339–344. doi:10.1111/ijd.12783
  • Wang YX, Chen XW, Wang SB, et al. Association between androgenic alopecia and coronary artery disease: a cross-sectional study of han Chinese male population. Int J Gen Med. 2021;14:4809–4818. doi:10.2147/IJGM.S326812
  • AbdElneam AI, Al-Dhubaibi MS, Bahaj SS, Mohammed GF, Atef LM. Apo B-48 gene expression and low-density lipoprotein as a factor for increased insulin resistance and severity of acne. Gene. 2023;885:147703. doi:10.1016/j.gene.2023.147703
  • Dannecker C, Wagner R, Peter A, et al. Low-density lipoprotein cholesterol is associated with insulin secretion. J Clin Endocrinol Metab. 2021;106(6):1576–1584. doi:10.1210/clinem/dgab147
  • He H, Feng J, Zhang S, et al. The apolipoprotein B/A1 ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome. Front Endocrinol. 2021;12:773781. doi:10.3389/fendo.2021.773781
  • Yang G, Schooling CM. Investigating sex-specific associations of lipid traits with type 2 diabetes, glycemic traits and sex hormones using Mendelian randomization. Cardiovasc Diabetol. 2023;22(1):3. doi:10.1186/s12933-022-01714-2
  • Li K, Sun Y, Liu S, et al. The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia. Int J Biol Sci. 2023;19(11):3307–3323. doi:10.7150/ijbs.80481
  • Kobayashi S, Moriya H, Negishi K, Maesato K, Ohtake T. LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb. J Clin Apher. 2003;18(3):115–119. doi:10.1002/jca.10055
  • Coban N, Onat A, Guclu-Geyik F, Can G, Sex- E-UN. and obesity-specific association of aromatase (CYP19A1) gene variant with apolipoprotein b and hypertension. Arch Med Res. 2015;46(7):564–571. doi:10.1016/j.arcmed.2015.09.004
  • Dai W, Li Y, Zheng H. Estradiol/Testosterone imbalance: impact on coronary heart disease risk factors in postmenopausal women. Cardiology. 2012;121(4):249–254. doi:10.1159/000337274
  • Suzuki K, Inoue M, Cho O, et al. Scalp microbiome and sebum composition in Japanese male individuals with and without androgenetic alopecia. Microorganisms. 2021;9:10. doi:10.3390/microorganisms9102132
  • Chaikittisilpa S, Rattanasirisin N, Panchaprateep R, et al. Prevalence of female pattern hair loss in postmenopausal women: a cross-sectional study. Menopause. 2022;29(4):415–420. doi:10.1097/GME.0000000000001927
  • Smythe CD, Greenall M, Kealey T. The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol. J Invest Dermatol. 1998;111(1):139–148. doi:10.1046/j.1523-1747.1998.00246.x
  • Chanprapaph K, Sutharaphan T, Suchonwanit P. Scalp biophysical characteristics in males with androgenetic alopecia: a comparative study with healthy controls. Clin Interv Aging. 2021;16:781–787. doi:10.2147/CIA.S310178
  • Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Scalp Seborrheic Dermatitis: what We Know So Far. Skin Appendage Disord. 2023;9(3):160–164. doi:10.1159/000529854